Literature DB >> 3094446

Antibiotic susceptibility of clinical isolates of Pseudomonas aeruginosa.

C Cervantes-Vega, J Chavez, M G Rodriguez.   

Abstract

Three hundred and twenty two clinical isolates of Pseudomonas aeruginosa collected in Morelia, México, were analyzed for in vitro susceptibility to five antibiotics by agar dilution tests. Antibiotic resistance was shown by 50% of total isolates. Frequencies of resistance were: streptomycin, 47%; gentamicin, 13%; tobramycin, 8%; and carbenicillin, 7%; no amikacin resistance was found. The more common resistance patterns were streptomycin, gentamicin-streptomycin, and tobramycin-gentamicin-streptomycin. Resistance to either tobramycin, gentamicin or carbenicillin was found mainly in pyocin type 10 isolates. The proportion of antibiotic resistant isolates ranged from 37 to 75% in four hospitals, and amounted 24% in three clinical laboratories.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094446     DOI: 10.1007/bf00428643

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  16 in total

1.  Pyocin types of clinical strains of Pseudomonas aeruginosa isolated in Morelia, México (1980-1984).

Authors:  C Cervantes Vega; J Chávez; M E Padilla; A N Rivera; S Vaca
Journal:  Rev Latinoam Microbiol       Date:  1986 Oct-Dec

2.  Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa.

Authors:  G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

3.  Antibiotic use among medical specialties in a community hospital.

Authors:  G J Jogerst; S E Dippe
Journal:  JAMA       Date:  1981-02-27       Impact factor: 56.272

4.  Third type of plasmid conferring gentamicin resistance in Pseudomonas aeruginosa.

Authors:  D I Smith; R G Lus; M C Rubio Calvo; N Datta; A E Jacob; R W Hedges
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

5.  Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.

Authors:  N J Legakis; M Aliferopoulou; J Papavassiliou; M Papapetropoulou
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

6.  The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.

Authors:  K V Rolston; P H Chandrasekar; J L LeFrock; R F Schell
Journal:  Chemotherapy       Date:  1984       Impact factor: 2.544

7.  A three-year study of nosocomial infections associated with Pseudomonas aeruginosa.

Authors:  R J Sherertz; F A Sarubbi
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

Review 8.  Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends.

Authors:  A Cross; J R Allen; J Burke; G Ducel; A Harris; J John; D Johnson; M Lew; B MacMillan; P Meers
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

9.  Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11.

Authors:  J J Farmer; R A Weinstein; C H Zierdt; C D Brokopp
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

10.  Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.

Authors:  J A Washington; R J Snyder; P C Kohner; C G Wiltse; D M Ilstrup; J T McCall
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

View more
  2 in total

1.  Susceptibility to mercurials of clinical Pseudomonas aeruginosa isolated in México.

Authors:  C Cervantes-Vega; J Chávez
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

2.  Arctic Psychrotolerant Pseudomonas sp. B14-6 Exhibits Temperature-Dependent Susceptibility to Aminoglycosides.

Authors:  Minjeong Kang; Tae-Rim Choi; Soyeon Ahn; Hee Young Heo; Hyerim Kim; Hye Soo Lee; Yoo Kyung Lee; Hwang-Soo Joo; Philip S Yune; Wooseong Kim; Yung-Hun Yang
Journal:  Antibiotics (Basel)       Date:  2022-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.